Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: A case series

International Journal of Artificial Organs

Volumn 39, Issue 3, 2016, Pages 141-146

  Träger, Karl ^a   Fritzler, Daniel ^a   Fischer, Guenther ^a   Schröder, Janpeter ^a   Skrabal, Christian ^a   Liebold, Andreas ^a   Reinelt, Helmut ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiopulmonary bypass; CRRT; Cytokines; CytoSorb; Hemoadsorption; SIRS

Indexed keywords

HEMODYNAMICS;

% REDUCTIONS; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; CONTINUOUS RENAL REPLACEMENT THERAPY; CYTOKINES; CYTOSORB; HAEMODYNAMICS; HEMOADSORPTION; RENAL REPLACEMENT THERAPIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES;

CARDIOVASCULAR SURGERY;

CYTOKINE;

ADSORPTION; ADVERSE EFFECTS; AGED; BLOOD; CARDIOPULMONARY BYPASS; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; VERY ELDERLY;

ADSORPTION; AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; COMBINED MODALITY THERAPY; CYTOKINES; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 84968830808     PISSN: 03913988     EISSN: 17246040     Source Type: Journal    
DOI: 10.5301/ijao.5000492     Document Type: Article

References (18)

1. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61(6):1714-1720.
2. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232-244.
3. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004;32(3):801-805.
4. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008;36(5):1573-1577.
5. Peng ZY, Wang HZ, Carter MJ, et al. Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 2012;81(4):363-369.
6. Namas RA, Namas R, Lagoa C, et al. Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies. Mol Med. 2012;18:1366-1374.
7. Schädler D, Porzelius C, Jörres A, et al. A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients. Crit Care. 2013;17(2): 62.
8. Born F, Pichlmaier M, Peterβ S, et al. Systemic Inflammatory Response Syndrome in Heart Surgery: New possibilities for treatment through the use of a cytokine adsorber during ECC? Kardiotechnik 2/2014 http://www.cytosorbents.com/pdf/Born_KardioTechnik_2014_-_English_Translation.pdf. Accessed April 6, 2016.
9. Bruenger F, Kizner L, Weile J, Morshuis M, Gummert JF. First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015;38(2):113-116.
10. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422-426.
11. Mitzner SR, Gloger M, Henschel J, Koball S. Improvement of hemodynamic and inflammatory parameters by combined hemoadsorption and hemodiafiltration in septic shock: a case report. Blood Purif. 2013;35(4):314-315.
12. Song M, Winchester J, Albright RL, Capponi VJ, Choquette MD, Kellum JA. Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004;22(5):428-434.
13. Bone RC, Balk RA, Cerra FB, et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/ Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655.
14. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3(2): 129-140.
15. Kidney Disease; Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Inter. 2012;2:1-138. http://kdigo.org/home/guidelines/acute-kidney-injury. Accessed April 6, 2016.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
17. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling – regulation of the immune response in normal and critically ill states. Crit Care Med 2000;28(4): 3-12.
18. Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457-2464.